loading page

Fabrication of FSP/nHAP-Based Monolayer/Bilayer Membranes for Drug Carrier Applications
  • +1
  • Funda ÖZDEMİR GÜNEY,
  • Serkan DAYAN,
  • Emrah SOYLU,
  • Fatih Duman
Funda ÖZDEMİR GÜNEY
Erciyes Universitesi Eczacilik Fakultesi
Author Profile
Serkan DAYAN
Erciyes Universitesi Eczacilik Fakultesi

Corresponding Author:[email protected]

Author Profile
Emrah SOYLU
Erciyes Universitesi Dis Hekimligi Fakultesi
Author Profile
Fatih Duman
ERNAM − Erciyes University Nanotechnology Application and Research Center
Author Profile

Abstract

Hydroxyapatite (HAP) is a biomaterial commonly used as a regenerative scaffold in bone, dental, and connective tissue engineering. Fish scales are a valuable source of hydroxyapatite due to their natural composition. In this study, fish scale waste was effectively converted into fish scale powder (FSP), which served as a viable source of hydroxyapatite. Subsequently, fish scale powder (FSP) combined with nano-hydroxyapatite (nHAP) was used to produce dental membranes as monolayers/bilayers. The physical and chemical characterization of the membranes was performed using various techniques, such as Fourier transform infrared spectroscopy (FT-IR), X-ray diffraction analysis (XRD), field emission scanning electron microscopy (FESEM), energy dispersive X-ray spectroscopy (EDX), and mapping analysis. These membranes were loaded with methotrexate (MTX), and the MTX release after 30, 60, 120, and 240 minutes was evaluated by UV-Vis spectrophotometry. The data showed that the amount of MTX released increased over time, and the membranes exhibited high encapsulation efficiencies ranging from 81.47% to 96.43% at 240 minutes. These novel biocompatible and cost-effective membranes have significant potential for various applications in dentistry and related fields, improving the efficiency of the healing process by increasing the amount of drug released over time.
13 Oct 2024Submitted to Microscopy Research and Technique
14 Oct 2024Submission Checks Completed
14 Oct 2024Assigned to Editor
15 Oct 2024Review(s) Completed, Editorial Evaluation Pending
17 Oct 2024Reviewer(s) Assigned